Calvete J J, McGregor J L, Rivas G, González-Rodríguez J
Instituto de Química Física, C.S.I.C., Madrid, Spain.
Thromb Haemost. 1987 Aug 4;58(2):694-7.
Membrane glycoproteins IIb and IIIa play a major role in human blood platelet aggregation. The absence or the severe reduction of these two membrane glycoproteins, as observed in platelets of Glanzmann's thrombasthenic patients, is related to a lack of platelet aggregation. Separation of Glanzmann's thrombasthenic platelet samples by two-dimensional polyacrylamide O'Farrell gels show the absence of a high and several low molecular mass glycoproteins, in addition to the loss of glycoproteins IIb and IIIa (McGregor J. L. et al. Eur. J. Biochem. 1981; 116: 379-388). The aim of this study was to identify the nature of the high molecular mass component, absent in thrombasthenic platelets. A high molecular mass glycoprotein (200 kDa), present in two-dimensional SDS-polyacrylamide O-Farrell gel separations, was recognized by a monoclonal antibody (MP37) directed against glycoprotein IIIa. Moreover, the tryptic peptide map of this high molecular mass glycoprotein was nearly identical to that of glycoprotein IIIa. These results indicate that this high molecular mass glycoprotein present in SDS-polyacrylamide gels is a dimer of glycoprotein IIIa. This work raises the possibility that the high molecular mass glycoprotein, absent in two-dimensional O'Farrell gel separations of thrombasthenic platelets, is a dimer of glycoprotein IIIa.
膜糖蛋白IIb和IIIa在人体血小板聚集中起主要作用。正如在Glanzmann血小板无力症患者的血小板中所观察到的,这两种膜糖蛋白的缺失或严重减少与血小板聚集缺乏有关。通过二维聚丙烯酰胺O'Farrell凝胶对Glanzmann血小板无力症血小板样本进行分离,结果显示除了糖蛋白IIb和IIIa缺失外,还缺少一种高分子量和几种低分子量糖蛋白(McGregor J. L.等人,《欧洲生物化学杂志》,1981年;116: 379 - 388)。本研究的目的是确定血小板无力症血小板中缺失的高分子量成分的性质。在二维SDS - 聚丙烯酰胺O - Farrell凝胶分离中存在的一种高分子量糖蛋白(200 kDa),可被一种针对糖蛋白IIIa的单克隆抗体(MP37)识别。此外,这种高分子量糖蛋白的胰蛋白酶肽图与糖蛋白IIIa的几乎相同。这些结果表明,SDS - 聚丙烯酰胺凝胶中存在的这种高分子量糖蛋白是糖蛋白IIIa的二聚体。这项工作提出了一种可能性,即在血小板无力症血小板的二维O'Farrell凝胶分离中缺失的高分子量糖蛋白是糖蛋白IIIa的二聚体。